CCNA2 and myocardial infarction: Similar results were also seen in cyclin A2-overexpressing transgenic mice, including the induction of cardiac regeneration, reduced scarring, improved LV function, and prevention of heart failure after myocardial infarction (Cheng et al., 2007).